Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database

Cecilia T. Ong,Brittany Morgan Campbell,Samantha M. Thomas,Rachel A. Greenup,Jennifer K. Plichta,Laura H. Rosenberger,Jeremy Force,Allison Hall,Terry Hyslop,E. Shelley Hwang,Oluwadamilola M. Fayanju

Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database

2018

Cecilia T. Ong
Brittany Morgan Campbell
Samantha M. Thomas
Rachel A. Greenup
Jennifer K. Plichta
Laura H. Rosenberger
Jeremy Force
Allison Hall
Terry Hyslop
E. Shelley Hwang
Oluwadamilola M. Fayanju

Background Metaplastic breast cancer (MBC) is characterized by chemoresistance and hematogenous spread. We sought to identify factors associated with improved MBC outcomes and increased likelihood of MBC diagnosis.

Keywords:

Breast cancer
Hematogenous Spread
Internal medicine
Medicine
Oncology
General surgery
retrospective analysis
Surgical oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations